Given the pro-survival role of STAT3 in PEL cells and given that the activity of this transcription factor may be influenced by its methylation or that of promoters of genes encoding for proteins inhibiting it, in the present study, we explored the impact of DNA- or histone-demethylating agents on STAT3 activation. Here, STAT3 is linked to primary effusion lymphoma.